Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.65
Bid: 18.50
Ask: 18.80
Change: -0.10 (-0.53%)
Spread: 0.30 (1.622%)
Open: 18.75
High: 0.00
Low: 0.00
Prev. Close: 18.75
CAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on refinancing and current trading

17 Aug 2020 07:00

RNS Number : 2539W
Carclo plc
17 August 2020
 

Carclo plc

 

("Carclo" or "the Group" or "the Company")

 

Update on refinancing and current trading

 

 

Tripartite financing agreement secured

 

The Board announces that on 14 August 2020, the Group agreed revised funding arrangements with the Company's main secured creditors, HSBC and the Pension Scheme, which provide access to ongoing bank facilities as well as visibility over repayment schedules through to July 2023.

 

As part of this agreement, new facilities have been entered into with the Group's lending bank, HSBC, which comprise a Term Loan of £34.5m and a Revolving Credit Facility of £3.5m. In parallel to this, the Group reached agreement with the Trustees of the Pension Scheme in respect of both the actuarial deficit and the resultant deficit repair contributions to be made over the next three years; £2.8m (2021), £3.9m (2022) and £3.8m (2023).

 

As previously announced, securing a suitable long-term funding position for the Group has been a key focus of the Board. With a more stable base now established, the Board can turn its focus to delivering its growth strategy aimed at capturing the significant long-term opportunities it sees for the Group.

 

Update on current trading

 

Group revenue for the continuing businesses for the first quarter was 12% lower than the same period last year. In anticipation of a material reduction in activity in both businesses during the first quarter, the Group implemented a number of operating and commercial initiatives aimed at preserving operational continuity as well as matching cost to reduced demand. The Group has also been able to access Covid-19 relief schemes, particularly in relation to job retention programmes, in a number of its territories including for the UK and US operations. As a result of an effective response by the business, and more resilient demand conditions in certain segments, the overall trading performance in the first quarter of the Group's current financial year to 31 March 2021 was ahead of the Board's initial, Covid-19 adjusted, planning assumptions with both the Technical Plastics and Aerospace divisions recording encouraging performances. Group net debt excluding IFRS16 lease liabilities as at 27 June 2020 was £24.2m (31 March 2020: £22.1m).

 

The Technical Plastics business benefited from robust demand for products relating to Covid-19 testing, which partially offset a reduction in demand for other products in both the medical diagnostics and industrial sectors that had been exacerbated by the impact of government-imposed lockdown of a customer's facility in India. The business was also successful in securing a number of new tooling orders in the medical diagnostics sector which are expected to deliver significant production volumes in future years.

 

The Aerospace Division performed better than anticipated in the first quarter, largely as a result of continued offtake from the existing orderbook, which partly offset the impact of a significant reduction in both newbuild and spares demand from Airbus.

 

Outlook

 

In light of the ongoing uncertainty presented by the pandemic, as well as any wider resultant economic impacts, the Board does not believe that it is possible to provide detailed guidance for the year ending 31 March 2021 at this time. Activity levels in July were broadly in line with those seen in the first quarter and the Board remains cautious about market conditions in the near term. The Group will continue to take action to reduce its cost base, where appropriate, to mitigate the effect of any reduction in demand, whilst seeking to preserve the capability and capacity to respond positively as conditions improve.

 

The Board expects to release the Group's preliminary results on 25 August 2020.

 

Enquiries:

 

FTI Consulting 020 3727 1340

Nick Hasell / Susanne Yule

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDKKABKDBKBAFD
Date   Source Headline
24th May 201010:02 amRNSHolding(s) in Company
7th May 20104:49 pmRNSHolding(s) in Company
8th Apr 20107:00 amRNSPre-close trading statement
7th Apr 20103:30 pmRNSCDT and CIT demonstrate ITO-Free lighting panel
31st Mar 201010:19 amRNSHolding(s) in Company
22nd Mar 20104:27 pmRNSHolding(s) in Company
2nd Mar 20104:07 pmRNSHolding(s) in Company
25th Feb 20107:00 amRNSHolding(s) in Company
11th Feb 20107:00 amRNSInterim Management Statement
3rd Feb 20101:27 pmRNSHolding(s) in Company
2nd Feb 201012:41 pmRNSHolding(s) in Company
8th Jan 20109:26 amRNSHolding(s) in Company
4th Jan 20102:32 pmRNSTotal Voting Rights
4th Jan 20102:29 pmRNSHolding(s) in Company
4th Jan 20101:31 pmRNSHolding(s) in Company
24th Dec 200911:34 amRNSHolding(s) in Company
23rd Dec 20093:04 pmRNSHolding(s) in Company
22nd Dec 20092:06 pmRNSHolding(s) in Company
22nd Dec 20091:22 pmRNSHolding(s) in Company
17th Dec 20093:43 pmRNSPerformance Share Plan Award
16th Dec 20092:22 pmRNSDirector/PDMR Shareholding
16th Dec 200912:49 pmRNSDirector/PDMR Shareholding
16th Dec 20097:00 amRNSIssue of Equity
8th Dec 20097:00 amRNSAgreement with Atmel Corporation
24th Nov 20097:00 amRNSHalf Yearly Report
2nd Oct 20097:00 amRNSHalf Year Trading Update
4th Sep 20091:13 pmRNSResult of AGM
3rd Sep 20091:53 pmRNSHolding(s) in Company
13th Aug 20097:00 amRNSInterim Management Statement
12th Aug 20091:29 pmRNSHolding(s) in Company
30th Jul 20094:11 pmRNSHolding(s) in Company
1st Jul 20091:49 pmRNSHolding(s) in Company
24th Jun 20094:07 pmRNSDirector/PDMR Shareholding
9th Jun 20097:00 amRNSFinal Results
7th Apr 20097:00 amRNSPre-close trading update
4th Feb 20097:00 amRNSInterim Management Statement
21st Jan 20095:09 pmRNSDirectors's disclosure update
5th Dec 20082:13 pmRNSDirector/PDMR Shareholding
25th Nov 20087:00 amRNSInterim Results
25th Sep 20087:00 amRNSHalf year trading update
5th Sep 20089:39 amRNSResult of AGM
19th Aug 20087:00 amRNSInterim Management Statement
8th Aug 20083:01 pmRNSApproval for Xennia sale of C
16th Jun 20083:36 pmRNSDirector/PDMR Shareholding
10th Jun 20087:00 amRNSFinal Results
22nd May 200810:00 amRNSNotice of Results
8th Apr 20087:01 amRNSPre-Close Update
14th Feb 20083:30 pmRNSHolding(s) in Company
6th Feb 20087:00 amRNSInterim Management Statement
29th Nov 20071:20 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.